Navigation Links
Amsco® 3080/3085 SP™ Bariatric Orthopedic Extension

ProductsAmsco® 3080/3085 SP™ Bariatric Orthopedic Extension
Company STERIS Corporation
Item Amsco® 3080/3085 SP™ Bariatric Orthopedic Extension
Features Includes:
  • Abductor bar assembly
  • Wedge-shaped sacral rest with pad (adult)
  • Perineal post with pad (adult)
  • Traction unit assembly (qty. two)
  • Patient transfer board with fout-inch (102-mm) pad
  • L-shaped traction extensions (qty. two)
  • Pair of foot traction boots (adult)
  • traction accessory clamp (qty. two)
  • Anesthesia armboard with two-inch (51-mm) pad
  • Universal legholder
  • Multi-posture armboard with two-inch (51-mm) pad
  • Clark socket
  • Accessory cart
  • Setup procedure guide
  • Description A 3080/3085 orthopedic extension serves as a mobile, radiolucent orthopedic platform. When not in use, accessories can be removed and stored in cart.
    Info STERIS Corporation
    Customer Service: (800) JIT-4-USE
    Web site: http://www.steris.com

    Related medicine products :

    1. Amsco® 3080/3085 SP™ Bariatric Foot Extension
    2. Amsco® 3080/3085 SP™ Bariatric Table Extensions
    3. Amsco® Power-Lift Stirrups
    4. Amsco® Auto Lift Multi-Purpose Stirrups
    5. Amsco® Power-Lift Bariatric Stirrups
    6. ENDO GRASP™ 5 mm Instrument With on/off Ratchet Switch
    7. ROTICULATOR ENDO GRASP™ 5 mm Instrument With Spin Lock
    8. OLERUP SSP™ HLA Kits
    9. Bariatric Knee Immobilizer
    10. Bariatric Universal Leg Brace
    11. Bariatric Laparoscopes
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    Medicine Products:
    (Date:12/9/2016)... ... December 09, 2016 , ... The Holy Name ... New York, NY, on December 3rd, to benefit Holy Name Medical Center's programs ... event, which raised over $1 million - the largest event in the Center's ...
    (Date:12/9/2016)... ... December 09, 2016 , ... The ... Cable Network (PCN) during the summer of 2016. The program was made possible ... the United States Department of Health and Human Services Administration. The broadcast, ...
    (Date:12/8/2016)... ... December 08, 2016 , ... After enjoying record-breaking attendance at ... for its 33rd Annual Issues & Research Conference, March 2-3, 2017, at ... the conference is “Persistent Challenges and New Opportunities: Using Research to Accelerate the ...
    (Date:12/8/2016)... ... December 08, 2016 , ... Seavest Healthcare Properties ... by an affiliate of Seavest, has won a prestigious national healthcare real estate ... ambulatory care center (ACC) was named “Best New Development, MOBs and Other Outpatient ...
    (Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, ... Mouth?” (WIYM) campaign to inform dentists and patients about the safety issues related to ... prosthetic market in the U.S. is projected to reach $6.4 billion in 2018 with ...
    Breaking Medicine News(10 mins):
    (Date:12/9/2016)... Dec 9, 2016 Research and Markets has ... report to their offering. ... The global travel vaccines market to grow at ... report covers the present scenario and the growth prospects of the ... the report considers the revenue generated from the sales of various ...
    (Date:12/9/2016)... , Dec. 9, 2016  Axovant Sciences ... clinical-stage biopharmaceutical company focused on the treatment of ... data from a Phase 2b trial evaluating treatment ... donepezil, compared with donepezil plus placebo in people ... the addition of intepirdine to treatment was associated ...
    (Date:12/8/2016)... , Dec. 8, 2016 IRIDEX Corporation (NASDAQ: ... offer newly issued shares of common stock, $0.01 par value ... an underwritten public offering.  The final terms of the Offering ... of pricing, and there can be no assurance as to ... IRIDEX expects to use the net proceeds it will receive ...
    Breaking Medicine Technology: